Key result
HARS score predicts 3-month MACE with AUC 0.80 in chest pain patients with normal hs-cTn.
Why the study?
Does the HARS risk score accurately predict 3-month MACE in emergency department patients with acute chest pain and normal high-sensitivity troponin I?
Cohort (n=1,076)
No
Does the HARS risk score accurately predict 3-month MACE in emergency department patients with acute chest pain and normal high-sensitivity troponin I?
Effect estimate: AUC 0.80 (95% CI 0.76-0.83)
The HARS risk score is a simple, validated tool that accurately stratifies the 3-month risk of MACE in emergency department patients presenting with acute chest pain and normal high-sensitivity troponin I.
May aid ED triage in normal-troponin chest pain; hypothesis-generating pending prospective validation.
A new risk score was developed for acute chest pain patients without known CAD and ST-segment deviation and with normal hs-TnI and may aid MACE risk assessment and patient triage in the ED.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2022) conducted a cohort in Acute chest pain with normal high-sensitivity troponin I (n=1,076). HARS risk score was evaluated on Major adverse cardiac events (MACE) within 3 months (AUC 0.80, 95% CI 0.76-0.83). The HARS risk score accurately predicted 3-month major adverse cardiac events with an AUC of 0.80 in patients presenting to the emergency department with acute chest pain and normal high-sensitivity troponin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: